September 2, 2008

VALEANT PHARMA: Expecting Dismissal from Permax Liability Case

COMPANIES: Amarin Corp | Amarin Pharmaceuticals Inc | Athena Neurosciences Inc | Elan Pharmaceuticals | Eli Lilly & Co | Valeant Pharmaceuticals International fka ICN Pharmaceuticals Inc
Subscribe

Valeant Pharmaceuticals International, in its Form 10-Q dated Aug. 11, 2008, disclosed that it expects to be dismissed with prejudice from Kathleen M. O’Connor’s product liability lawsuit on Permax soon.

On Feb. 8, 2007, the Company was served with the…

TO CONTINUE READING,LOGIN or
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Earnings | Health Care | Legal Issues, Litigation | Loans & Financing | Medical Supplies | Medical Technology | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | Illinois | North America | United States